Long-Term Outcomes of Laparoscopic Sleeve Gastrectomy: A 10+ Year Review

Overview

Laparoscopic sleeve gastrectomy (LSG) demonstrates sustained metabolic benefits with an average total weight loss of 24.4% and remission rates of 45.6% for type 2 diabetes and 41.4% for hypertension at 10 or more years post-surgery. However, one-third of patients develop de novo gastro-esophageal reflux disease (GERD), and nearly 20% require revisional surgery, predominantly Roux-en-Y gastric bypass.

Background

Obesity prevalence is projected to reach 51% by 2030, making effective treatments critical. Metabolic and bariatric surgery, particularly LSG, has become the most commonly performed procedure since 2014 due to its safety and short-term efficacy. Despite initial success, concerns have emerged regarding long-term complications such as GERD and Barrett’s esophagus, as well as variable effectiveness in patients with high BMI. This review synthesizes data from studies with follow-up periods of 10 years or more to evaluate the durability of LSG outcomes.

Data Highlights

Key Findings

• LSG achieves a sustained average total weight loss of 24.4% at 10+ years postoperatively.
• Remission rates for type 2 diabetes and hypertension are 45.6% and 41.4%, respectively, though some studies report no diabetes remission.
• De novo GERD develops in approximately one-third of patients, with a low incidence (0.5%) of Barrett’s esophagus reported.
• Revisional surgery is required in about 19.2% of patients, most commonly conversion to Roux-en-Y gastric bypass to address GERD or weight recurrence.
• There is variability in surgical techniques, follow-up rates, and definitions of weight regain across studies, which may influence outcomes.
• Long-term data remain limited, with most studies being retrospective and follow-up rates varying between 44% and 100%.

Clinical Implications

Clinicians should consider LSG as an effective long-term metabolic surgery option with durable weight loss and remission of obesity-related comorbidities. However, patients must be counseled about the significant risk of developing GERD and the potential need for revisional surgery. Regular postoperative monitoring for reflux symptoms and timely endoscopic evaluation are advisable to detect complications early.

Conclusion

Laparoscopic sleeve gastrectomy provides substantial and lasting metabolic benefits over a decade, but the notable incidence of GERD and revisional surgery underscores the need for careful patient selection and long-term follow-up. Further prospective studies are warranted to optimize surgical techniques and management strategies.

References

1. Marceau et al. 1998 -- Introduction of Sleeve Gastrectomy
2. Ren et al. 1999 -- Laparoscopic Approach to Sleeve Gastrectomy
3. Gumbs et al. 2007 -- Recommendation of SG as Stand-Alone MBS
4. SLEEVEPASS Trial 2020 -- 10-Year Outcomes of SG vs Gastric Bypass
5. IFSO Task Force 2021 -- Barrett’s Esophagus Incidence Post-SG